Key result
Low mean and high variability of HDL-C linked to ~47% higher risk of MI.
Why the study?
Although low HDL-C and HDL-C variability predict cardiovascular risk in coronary artery disease, their combined effect on MI, stroke, and mortality in the general population remained unclear.
Does the combination of low mean HDL-C and high visit-to-visit HDL-C variability increase the risk of myocardial infarction, stroke, and all-cause mortality in the general population?
Cohort (n=5,433,098)
Yes
Does the combination of low mean HDL-C and high visit-to-visit HDL-C variability increase the risk of myocardial infarction, stroke, and all-cause mortality in the general population?
In a general population cohort of over 5.4 million individuals, low mean HDL-C and high visit-to-visit HDL-C variability independently and additively increased the risk of myocardial infarction, stroke, and all-cause mortality.
Answers are grounded in this paper and cite their sources.
HDL-C variability may refine risk stratification; extends observational data but leaves causal and interventional implications open.
Background A low level of high-density lipoprotein-cholesterol (HDL-C) is a well-known risk factor for cardiovascular events. Recent studies have also suggested that HDL-C variability has a predictive role in patients with coronary artery disease. We investigated the combined effect of the mean and variability of HDL-C on the risk of myocardial infarction (MI), stroke, and mortality in the general population. Methods and Results We selected 5 433 098 subjects in the Korean National Health Insurance System cohort who had no history of MI or stroke and who underwent ≥3 health examinations between 2009 and 2013. Visit-to-visit HDL-C variability was calculated using the coefficient of variation, variability independent of the mean and average real variability. The low-mean and high-variability groups were defined as the lowest and highest quartiles of HDL-C mean and variability, respectively. There were 27 605 cases of MI, 31 162 cases of stroke, and 50 959 deaths during the median follow-up of 5.1±0.6 years. A lower mean or higher variability (coefficient of variation) of HDL-C was associated with a higher risk of adverse outcomes, and the 2 measures had an additive effect. In the multivariable-adjusted model, the hazard ratios (95% CIs) of the low-mean/high-variability group compared with the high-mean/low-variability group were 1.47 (1.41-1.54) for MI, 1.23 (1.18-1.28) for stroke, and 1.41 (1.36-1.45) for all-cause mortality. Results were consistent when variability was modeled using variability independent of the mean or average real variability, and in various sensitivity and subgroup analyses. Conclusions Low mean and high variability of HDL-C is associated with an increased risk of MI, stroke, and mortality.
No takes yet. Share an insight, caveat, or question.
Han et al. (2020) conducted a cohort in General population free of prior myocardial infarction or stroke (n=5,433,098). Low mean (lowest quartile) and high visit-to-visit variability (highest quartile of coefficient of variation) of HDL-C vs. High mean (quartiles 2-4) and low visit-to-visit variability (quartiles 1-3) of HDL-C was evaluated on Newly diagnosed myocardial infarction (HR 1.47, 95% CI 1.41-1.54). Low mean and high variability of HDL-C increased the risk of myocardial infarction, stroke, and mortality vs high mean/low variability.
Synapse has enriched 10 related papers. Consider them for comparative context: